BMD
EW icon

Better Money Decisions’s Edwards Lifesciences EW Stock Holding History

Better Money Decisions’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-62
Closed -$6K – 177
2022
Q2 		$6K Buy
+62
New +$6.42K 0.01% 364
2021
Q4 		– Sell
-62
Closed -$7K – 233
2021
Q3 		$7K Hold
62
– – 0.01% 460
2021
Q2 		$6K Hold
62
– – 0.01% 467
2021
Q1 		$5K Buy
+62
New +$5.24K 0.01% 443

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Better Money Decisions's EW Position: Q3 2022 in Review

Better Money Decisions sold out of Edwards Lifesciences (EW) in Q3 2022, closing a stake of 62 shares — an estimated $6K sold.

Better Money Decisions first reported a position in EW in Q1 2021 and held it in 4 quarters. The position peaked at $7K in Q3 2021. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.

  • Better Money Decisions reported no remaining Edwards Lifesciences position as of Q3 2022 after selling out during the quarter.
  • Better Money Decisions sold 62 Edwards Lifesciences shares in Q3 2022, an estimated $6K.
  • Better Money Decisions first reported a position in Edwards Lifesciences in Q1 2021 and held it in 4 quarters.
  • Better Money Decisions's Edwards Lifesciences position peaked at $7K in Q3 2021.
  • 1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on Better Money Decisions's 13F filing for Q3 2022, filed 28 Oct 2022.